![Infinity Pharmaceuticals Inc](/common/images/company/N_INFI.png)
Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a potential first-in-class, oral, immuno-oncology...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | -0.1682 | -83.9321357285 | 0.2004 | 0.2339 | 0.0233 | 5289026 | 0.11251111 | CS |
156 | -2.5078 | -98.7322834646 | 2.54 | 3.89 | 0.0233 | 1965863 | 1.58703001 | CS |
260 | -1.6078 | -98.0365853659 | 1.64 | 5.98 | 0.0233 | 1504899 | 2.0436499 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.